Concomitant Ruxolitinib and Ibrutinib for Graft-Versus-Host Disease (GVHD): The First Reported Use in Pediatric Patients

Allogeneic hematopoietic stem cell transplant (alloHSCT) can be a life-saving treatment for patients with hematological disorders but far too often carries the feared complication of graft-versus-host disease (GVHD). The first-line treatment of GVHD is typically corticosteroids, but steroid-refracto...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagliardi, Thomas A, Milner, Jordan, Cairo, Mitchell S, Steinberg, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573080/
https://www.ncbi.nlm.nih.gov/pubmed/36258935
http://dx.doi.org/10.7759/cureus.29195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573080/
https://www.ncbi.nlm.nih.gov/pubmed/36258935
http://dx.doi.org/10.7759/cureus.29195

Ejemplares similares